MedTrace Logo

The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment

NCT05498558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-08-12

No results posted yet for this study

Summary

The incidence of re-ectopic pregnancy in patients with tubal ectopic pregnancy increases significantly, which may be related to the condition of the fallopian tubes, such as tubal inflammation, tubal obstruction and other high-risk factors that may lead to tubal ectopic pregnancy; it is also associated with the treatment of the previous tubal ectopic pregnancy. Compared with salpingectomy, the treatment of preserving the fallopian tubes increased the incidence of re-ectopic pregnancy while increasing the pregnancy rate of the patient. For tubal-preserving patients, the most common option currently used is to recommend that monitoring ovulation during each menstrual cycle if they choose to conceive naturally rather than IVF. If ovulation occures on the healthy side of the ovary, it may be considered to try to conceive; Otherwise, contraception is recommended. However, there are uncertainties about this option. Based on this, we intend to conduct a multicenter clinical trial to verify the effectiveness of the ovulation preparation regimen on the healthy side of ovary.

Conditions

  • Tubal-preserving Treatment of Tubal Ectopic Pregnancy
  • Tubal Pregnancy
  • Pregnancy Preparation

Interventions

OTHER

No intervention.

No intervention.

Sponsors & Collaborators

  • Shanghai 7th People's Hospital

    collaborator OTHER

  • Shanghai Zhoupu Hospital

    collaborator UNKNOWN

  • Shanghai Pudong Hospital

    collaborator OTHER

  • Shanghai First Maternity and Infant Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
41 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-10-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498558 on ClinicalTrials.gov